ArticleScientific reports2026

MTAP loss in gastrointestinal cancers is associated with CDKN2A deletion, poor prognosis in gastric carcinoma, and potential relevance for PRMT5-targeted therapy.

Su Ir Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.